ESCROW AGREEMENTEscrow Agreement • April 19th, 2012 • American Boarding Co • Nevada
AGREEMENT made as of the 28th day of March 2012 by and between American Boarding Company (“Issuer”), and the Law Offices of Harold P. Gewerter, Esq., Ltd., 5440 West Sahara, Suite 105, Las Vegas, Nevada 89146 (the “Escrow Agent”)
PATENT & Technology LICENSE AGREEMENT AGT. No. A2014-0164American Boarding Co • December 22nd, 2015 • Real estate • Ohio
This Patent & Technology License Agreement is between the Licensor and the Licensee identified below (collectively, “Parties”, or singly, “Party”).
CONSULTING AGREEMENTConsulting Agreement • December 22nd, 2015 • American Boarding Co • Real estate • New York
THIS CONSULTING AGREEMENT (the "Agreement") is made and entered into this day of May 21, 2015, (the "Effective Date") by and between Microlin Bio, Inc., a Delaware corporation duly organized under law and having an usual place of business at 302A W. 12 Street, Suite 114, New York, NY 10014 (hereinafter referred to as the "Company") and Bruce C. Galton (hereinafter referred to as the "Consultant") residing at 8 Holden Lane Madison, NJ 07940
PATENT & Technology LICENSE AGREEMENT AGT. No. A2014-0294American Boarding Co • December 22nd, 2015 • Real estate
This Patent & Technology License Agreement is between the Licensor and the Licensee identified below (collectively, “Parties”, or singly, “Party”).
MICROLIN BIO, INC. Scientific Advisory Board AgreementAdvisory Board Agreement • December 22nd, 2015 • American Boarding Co • Real estate • New York
This Scientific Advisory Board Agreement (the “Agreement”) is made and entered into as of December 18, 2013 (the “Effective Date”), by and between Microlin Bio, Inc., a Delaware company, having its principal place of business at 302A W. 12th Street, NY, NY 10014 (the “Company”), and Dr. George Calin, an individual with an address at 1515 Holcombe Blvd., Unit 1950, Houston, TX 77030-4009 (the “Advisor”). The Company and the Advisor may be referred to herein individually as “Party” or collectively, as “Parties.”
AGREEMENT AND PLAN OF MERGER by and amongAgreement and Plan of Merger • December 22nd, 2015 • American Boarding Co • Real estate • Delaware
THIS AGREEMENT AND PLAN OF MERGER is entered into as of December 17, 2015 by and among American Boarding Company, a Delaware corporation (“Parent”), Microlin Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”), and Microlin Bio, Inc. a Delaware corporation (the “Company”).
AMENDMENT NO. 1 TO LICENSE AGREEMENTLicense Agreement • December 22nd, 2015 • American Boarding Co • Real estate
This Amendment No. 1 to the License Agreement (“Amendment”), having an effective , date of April 7, 2014 (“Amendment Effective Date”), is made and entered by and between Ohio State Innovation Foundation, located at 1524 North High Street, Columbus, Ohio 43201 (“OSIF”) and Microlin Bio, Inc., a New York based corporation located at 302A West 12th, New York, NY 10014 (“Licensee”).
AMENDMENT NO. 1 TO LICENSE AGREEMENTLicense Agreement • December 22nd, 2015 • American Boarding Co • Real estate
This Amendment No. 1 to License Agreement (“Amendment”), having an effective date of January 15, 2014 (“Amendment Effective Date”), is made and entered by and between Ohio State Innovation Foundation, located at 1524 North High Street, Columbus, Ohio 43201 (“OSIF”) and MicroLin Bio, Inc., a New York corporation located at 302A W. 12th Street, Suite 114, New York, NY 10014 (“Licensee”).
MICROLIN BIO, INC. Scientific Advisory Board AgreementAdvisory Board Agreement • December 22nd, 2015 • American Boarding Co • Real estate • New York
This Scientific Advisory Board Agreement (the “Agreement”) is made and entered into as of September 18, 2013 (the “Effective Date”), by and between MicroLin Bio, Inc., a Delaware company, having its principal place of business at 302A W. 12th Street, NY, NY 10014 (the “Company”), and Dr. Philip Tsichlis, an individual with an address at 25 Jefferson Road, Winchester MA, 01890 (the “Advisor”). The Company and the Advisor may be referred to herein individually as “Party” or collectively, as “Parties.”
MICROLIN BIO, INC. Scientific Advisory Board AgreementAdvisory Board Agreement • December 22nd, 2015 • American Boarding Co • Real estate • New York
This Scientific Advisory Board Agreement (the “Agreement”) is made and entered into as of December 19, 2013 (the “Effective Date”), by and between MicroLin Bio, Inc., a Delaware company, having its principal place of business at 302A W. 12th Street, NY, NY 10014 (the “Company”), and Dr. Sakari Kauppinen, an individual with an address at Norskekrogen 12, DK-2765 Smoerum, Denmark (the “Advisor”). The Company and the Advisor may be referred to herein individually as “Party” or collectively, as “Parties.”
EMPLOYMENT AGREEMENTEmployment Agreement • December 22nd, 2015 • American Boarding Co • Real estate • New York
THIS EMPLOYMENT AGREEMENT (the “Agreement”) is entered into by Microlin Bio, Inc., a Delaware corporation with its principal business address at 302A West 12th Street Suite 114 New York, NY 10014 (the “Company”), and Joseph Hernandez, an individual residing at 635 West 42nd Street Apt. 11K (the “Executive”) July 15th, 2013 (the “Commencement Date”).
MICROLIN BIO, INC. Scientific Advisory Board AgreementAdvisory Board Agreement • December 22nd, 2015 • American Boarding Co • Real estate • New York
This Scientific Advisory Board Agreement (the “Agreement”) is made and entered into as of September 20, 2013 (the “Effective Date”), by and between MicroLin Bio, Inc., a Delaware company, having its principal place of business at 302A W. 12th Street, NY, NY 10014 (the “Company”), and Dr. Robert Lee, an individual with an address at 2300 Green Island Dr., Columbus, OH 43228 (the “Advisor”). The Company and the Advisor may be referred to herein individually as “Party” or collectively, as “Parties.”
INDEMNITY AGREEMENTIndemnity Agreement • December 22nd, 2015 • American Boarding Co • Real estate • New York
THIS INDEMNITY AGREEMENT (this "Agreement") is entered into as of December 17, 2015 by and between Reza Noorkayhani, an individual (the "Indemnitor"), and American Boarding Company, a Delaware corporation (“AMIB”), and Microlin Bio, Inc., a Delaware corporation (“Microlin”) (AMIB and Microlin are, collectively, the "Indemnitees").
Subscription AgreementAmerican Boarding Co • July 10th, 2012 • Real estate • Delaware
MICROLIN BIO INC. NONQUALIFIED STOCK OPTION AGREEMENTNonqualified Stock Option Agreement • December 22nd, 2015 • American Boarding Co • Real estate • Delaware
MicroLin Bio Inc., a Delaware corporation (the "Company"), grants to the Grantee named below, in accordance with the terms of the Microlin Bio Inc. Equity Incentive Plan (the "Plan") and this Nonqualified Stock Option Agreement (this "Agreement"), an option (the "Stock Option") to purchase the number of Shares at the exercise price per share ("Exercise Price") as follows:
SEPARATION AND DISTRIBUTION AGREEMENT BY AND AMONG AMERICAN BOARDING COMPANY, INC AND LUCKY REALTY, INC. Dated April 1, 2015Separation and Distribution Agreement • July 16th, 2015 • American Boarding Co • Real estate • Delaware
This SEPARATION AND DISTRIBUTION AGREEMENT, dated as of April 1, 2015 (this “Agreement”), is by and among American Boarding Company, a Delaware corporation (“ABC” the "Company"), and Lucky Realty, Inc., a Nevada corporation (“LRI”) and, together with ABC and LRI, the (“Parties”).
Subscription AgreementSubscription Agreement • April 19th, 2012 • American Boarding Co • Delaware
July 28, 2014American Boarding Co • December 22nd, 2015 • Real estate
Re: License Agreements/Upfront Fees/EquitvAmerican Boarding Co • December 22nd, 2015 • Real estate
This letter serves to confirm our agreement regarding Microlin's obligations with respect to the fees and expenses due to OSIF for the patents licensed from OSIF under the Agreements. The Agreements provide that Microlin is to pay OSIF an upfront fee (the “Upfront Fee"') for the licensed patents and to repay OSIF for past patent expenses (the "Patent Expenses"). The Agreements further provide that the Patent Expenses become immediately due and payable to OSIF in the event that $10,000,000 of external funding is obtained by Microlin.
Columbus, Ohio 43201 Re: License Agreements/Upfront Fees Dear Mr.Wright:American Boarding Co • December 22nd, 2015 • Real estate
This letter serves to confirm our agreement regarding Microlin's obligations with respect to the May 2014 Fee. Mkrolin acknowledges that it owes OSIF $500,000 on or before May 31, 2014 pursuant to the Agreements and OSIF agrees to defer Microlin's obligation to pay such amount on or before May 31, 2014 as set forth below. Microlin and OSIF agree that the May 2014 Fee will be paid in full from Microlin to OSIF via wire transfer no later than three (3) calendar days after the day on which Microlin delivers its registered securities to its underwriter(s) and receives payment for these securities (the "Closing Date"). In the event that the Closing Date does not occur or occurs after June 30, 2014, the parties will agree to a commercially reasonable alternati ve payment schedule.
Columbus, Ohio 43201 Re: License Agreements/Upfront Fees/Equity Dear Mr. Wright:American Boarding Co • December 22nd, 2015 • Real estate
This letter serves to confirm our agreement regarding Microlin's obligations with respect to the fees and expenses due to OSIF for the patents licensed from OSIF under the Agreements. The Agreements provide that Microlin is to pay OSIF an upfront fee (the "Upfront Fee") for the licensed patents and to repay OSIF for past patent expenses (the "Patent Expenses"). The Agreements further provide that the Patent Expenses become immediately due and payable to OSIF in the event that $I 0,000,000 of external funding is obtained by Microlin.
LICENSE AGREEMENTLicense Agreement • February 10th, 2016 • Microlin Bio, Inc • Real estate
BETWEEN: Université Laval, a private corporation duly incorporated under the provisions of an act of the National Assembly, sanctioned on December 8, 1970 (S.Q. 1970, c. 78), having its head office in Québec, Province of Québec, herein represented by Edwin Bourget who is the Vice-President for Research and Innovation, and who declares that he is duly authorized to act as representative of the University; (Hereafter designated as the “University”);
